To access this element change to forms mode OFF
Grant Award View - GA29899
Immunomodulatory Mast Cells as Therapeutic Agents in Chronic Autoimmune...
GA ID:
GA29899
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$631,653.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Immunomodulatory Mast Cells as Therapeutic Agents in Chronic Autoimmune and Acute Inflammatory Kidney Disease
Purpose:
MPO-ANCA associated glomerulonephritis and acute kidney injury are important causes of inflammatory kidney disease. In these diseases, specialised white blood cells called mast cells (MCs) enhance injurious inflammation by releasing packages of inflammatory proteins, a process called degranulation. This pre-clinical study will re-purpose an anti-allergy drug, disodium cromoglycate to prevent and or treat inflammatory kidney diseases.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1159361
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA